Biotech company Regeneron announced late-stage clinical trials of REGN-COV2, its investigational dual-antibody cocktail for the treatment and prevention of Covid-19, in a press release on Monday. Specifically, the statement noted that a Phase 3 trial of the drug will assess its ability to prevent coronavirus infection among uninfected people who …
Read More »Regeneron begins phase 3 testing of the Covid-19 antibody cocktail
